BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25245946)

  • 21. Endoplasmic reticulum stress sensitizes cells to DNA damage-induced apoptosis through p53-dependent suppression of p21(CDKN1A).
    Mlynarczyk C; Fåhraeus R
    Nat Commun; 2014 Oct; 5():5067. PubMed ID: 25295585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
    Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R
    Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene.
    Yoon JH; Choi WI; Jeon BN; Koh DI; Kim MK; Kim MH; Kim J; Hur SS; Kim KS; Hur MW
    J Biol Chem; 2014 Feb; 289(7):4018-31. PubMed ID: 24382891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KLHL4, a novel p53 target gene, inhibits cell proliferation by activating p21
    Choi SH; Cho SY; Song J; Hur MW
    Biochem Biophys Res Commun; 2020 Sep; 530(3):588-596. PubMed ID: 32753315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation.
    Lee YH; Bedford MT; Stallcup MR
    Genes Dev; 2011 Jan; 25(2):176-88. PubMed ID: 21245169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
    Falke D; Fisher MH; Juliano RL
    Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
    Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
    Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.
    Choi WI; Yoon JH; Kim MY; Koh DI; Licht JD; Kim K; Hur MW
    J Biol Chem; 2014 Jul; 289(27):18641-56. PubMed ID: 24821728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter.
    Álvaro-Blanco J; Urso K; Chiodo Y; Martín-Cortázar C; Kourani O; Arco PG; Rodríguez-Martínez M; Calonge E; Alcamí J; Redondo JM; Iglesias T; Campanero MR
    Nucleic Acids Res; 2017 Sep; 45(17):9960-9975. PubMed ID: 28973440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new coactivator function for Zac1's C2H2 zinc finger DNA-binding domain in selectively controlling PCAF activity.
    Hoffmann A; Spengler D
    Mol Cell Biol; 2008 Oct; 28(19):6078-93. PubMed ID: 18663001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.
    Wright DG; Marchal C; Hoang K; Ankney JA; Nguyen ST; Rushing AW; Polakowski N; Miotto B; Lemasson I
    Oncotarget; 2016 Jan; 7(2):1687-706. PubMed ID: 26625199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H3K9 histone methyltransferase G9a-mediated transcriptional activation of p21.
    Oh ST; Kim KB; Chae YC; Kang JY; Hahn Y; Seo SB
    FEBS Lett; 2014 Mar; 588(5):685-91. PubMed ID: 24492005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RB regulates transcription of the p21/WAF1/CIP1 gene.
    Decesse JT; Medjkane S; Datto MB; Crémisi CE
    Oncogene; 2001 Feb; 20(8):962-71. PubMed ID: 11314031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.
    Kuwahara Y; Charboneau A; Knudsen ES; Weissman BE
    Cancer Res; 2010 Mar; 70(5):1854-65. PubMed ID: 20179200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.
    Broude EV; Swift ME; Vivo C; Chang BD; Davis BM; Kalurupalle S; Blagosklonny MV; Roninson IB
    Oncogene; 2007 Oct; 26(48):6954-8. PubMed ID: 17486059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation.
    Weber A; Marquardt J; Elzi D; Forster N; Starke S; Glaum A; Yamada D; Defossez PA; Delrow J; Eisenman RN; Christiansen H; Eilers M
    EMBO J; 2008 Jun; 27(11):1563-74. PubMed ID: 18451802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
    Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
    Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.